Capricor Therapeutics CAPR
NASDAQ CAPR
$8.94 -0.53 (-5.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Net Equity Issued and Repurchased (2012 - 2026)

Updated

Capricor Therapeutics (CAPR) reported Net Equity Issued and Repurchased of $2.1 million for Q2 2026, compared with $19,580 a year earlier and up 42.6% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Capricor Therapeutics' Net Equity Issued and Repurchased came in at $240.53 million, up 62.4% year-over-year; for FY2025, it came in at $237.03 million, up 55.6% from FY2024.

  • Net Equity Issued and Repurchased has increased for three consecutive years, with a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $152.32 million in FY2024 (+497.0%), $25.52 million in FY2023 (+431.2%), $4.8 million in FY2022 (-76.2%) and $20.17 million in FY2021 (-26.2%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of -$1,543 in Q4 2021 and a high of $236.96 million in Q4 2025.
  • Year over year, Net Equity Issued and Repurchased gained in two of the last five quarters, with growth averaging 29.1%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2023 (growth of 692.4%); the low point was Q3 2025 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.47 million (Q1 2026), $236.96 million (Q4 2025) and $6,950 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 1.47 Mn
Dec 31, 2025 236.96 Mn
Sep 30, 2025 6,950.00
Jun 30, 2025 19,580.00
Mar 31, 2025 50,354.00
Dec 31, 2024 80.84 Mn
Sep 30, 2024 67.21 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 2.29 Mn
Dec 31, 2023 23.16 Mn
Sep 30, 2023 221,081.00
Jun 30, 2023 2.13 Mn
Mar 31, 2023 3,895.00
Dec 31, 2022 2.92 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 15,006.00
Mar 31, 2022 27,465.00
Dec 31, 2021 -1,543.00
Sep 30, 2021 6.56 Mn
API Access

Capricor Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CAPR&period=max&api_key=YOUR_API_KEY